Patents by Inventor Laetitia Arzoine

Laetitia Arzoine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VDAC1 compositions and methods of use thereof for regulating apoptosis
    Patent number: 8648045
    Abstract: The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC), polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: February 11, 2014
    Assignee: Ben Gurion University of the Negev Research and Development Authority Ltd.
    Inventors: Varda Shoshan-Barmatz, Salah Abu-Hamad, Laetitia Arzoine, Hilal Zaid
  • VDAC1 COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS
    Publication number: 20120214741
    Abstract: The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC), polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis.
    Type: Application
    Filed: February 15, 2012
    Publication date: August 23, 2012
    Applicant: BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY LTD.
    Inventors: Varda Shoshan-Barmatz, Salah Abu-Hamad, Laetitia Arzoine, Hilal Zaid
  • Voltage dependent anion channel (VDAC1) compositions and methods of use thereof for regulating apoptosis
    Patent number: 8119601
    Abstract: The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC)5 polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: February 21, 2012
    Assignee: Ben-Gurion University of the Negev Research and Development Authority Ltd.
    Inventors: Varda Shoshan-Barmatz, Salah Abu-Hamad, Laetitia Arzoine, Hilal Zaid
  • Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis
    Publication number: 20080274962
    Abstract: The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC)5 polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis.
    Type: Application
    Filed: March 9, 2006
    Publication date: November 6, 2008
    Applicant: Ben Gurion University of The Negev Research and De
    Inventors: Varda Shoshan-Barmatz, Salah Abu-Hamad, Laetitia Arzoine, Hilal Zaid